August 28, 2016 3:56 AM ET

Capital Markets

Company Overview of Inserm Transfert Initiative

Company Overview

Inserm Transfert Initiative is a venture capital firm specializing in incubation, pre-seed, seed, start-up, early and growth stages. It mainly targets investments in spin-offs from top tier academic research. The firm focuses on investments in the health, biotechnology, biomedicine, and life sciences sectors. It aims to invest in companies with economic activities in France. The firm invests between €0.1 million ($0.12 million) and €0.3 million ($0.36 million) in the healthcare sector, and an average of and €2 million ($2 million) in the life sciences sector. It seeks to invest between €1 million ($1.19 million) and €2 million ($2 million), made in one or multiple tranches. The firm may also...

5/7 rue Watt

Paris,  75013

France

Founded in 2005

Phone:

33 1 55 03 01 00

Key Executives for Inserm Transfert Initiative

Chief Executive Officer
Chief Executive Officer, President, Managing Partner, and Member of Advisory Committee
Communication Director
Compensation as of Fiscal Year 2016.

Inserm Transfert Initiative Key Developments

Inserm Transfert Initiative Presents at 9th Annual European Life Sciences CEO Forum & Exhibition, Mar-15-2016 through Mar-16-2016

Inserm Transfert Initiative Presents at 9th Annual European Life Sciences CEO Forum & Exhibition, Mar-15-2016 through Mar-16-2016. Venue: Hilton Zurich Airport Hotel, 27 Belsize Lane, London | NW3 5AS, United Kingdom. Presentation Date & Speakers: Mar-15-2016, François Thomas, President.

Inserm Transfer Initiative Presents at 15th Annual Biotech in Europe Forum for Global Partnering & Investment, Sep-30-2015 02:00 PM

Inserm Transfer Initiative Presents at 15th Annual Biotech in Europe Forum for Global Partnering & Investment, Sep-30-2015 02:00 PM. Venue: Congress Center, Basel, Switzerland. Speakers: François Thomas, Managing Partner.

Inserm Transfert Initiative Presents at BIO-Europe Spring 2015, Mar-09-2015

Inserm Transfert Initiative Presents at BIO-Europe Spring 2015, Mar-09-2015 . Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France.

Similar Private Companies By Industry

Company Name Region
2A Capital, SARL Europe
3S Finance Europe
66 NTH Europe
A+B Finance Europe
Abacuse Asset Management Europe

Recent Private Companies Transactions

Type
Date
Target
Private Placement
April 13, 2016
SIMARATO SAS
Merger/Acquisition
February 24, 2016
Effimune SA
Merger/Acquisition
February 1, 2016
Annapurna Therapeutics SAS
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Inserm Transfert Initiative, please visit www.inserm-transfert-initiative.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.